Hunan Jiudian Pharmaceutical Co., Ltd. (SHE:300705)
China
· Delayed Price · Currency is CNY 15.01
+0.10 (0.67%)
Mar 10, 2026, 3:04 PM CST
SHE:300705 Revenue
Hunan Jiudian Pharmaceutical had revenue of 756.09M CNY in the quarter ending September 30, 2025, a decrease of -3.03%. This brings the company's revenue in the last twelve months to 3.05B, up 3.64% year-over-year. In the year 2024, Hunan Jiudian Pharmaceutical had annual revenue of 2.93B with 8.85% growth.
Revenue (ttm)
3.05B
Revenue Growth
+3.64%
P/S Ratio
2.41
Revenue / Employee
1.37M
Employees
2,221
Market Cap
7.37B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.93B | 238.17M | 8.85% |
| Dec 31, 2023 | 2.69B | 366.30M | 15.75% |
| Jan 1, 2023 | 2.33B | 698.55M | 42.92% |
| Jan 1, 2022 | 1.63B | 649.51M | 66.40% |
| Dec 31, 2020 | 978.16M | 54.10M | 5.85% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiuzhitang | 1.94B |
| HARBIN GLORIA PHARMACEUTICALS Co., LTD | 2.25B |
| Hainan Haiyao | 825.66M |
| Sichuan Huiyu Pharmaceutical | 998.15M |
| Heilongjiang ZBD Pharmaceutical | 1.59B |
| Northeast Pharmaceutical Group | 6.85B |
| Frontier Biotechnologies | 143.67M |
| Shandong Wit Dyne Health | 2.36B |